In a trial of 131 TPO antibody-positive women diagnosed with SCH, levothyroxine replacement significantly reduced the rate of preterm delivery, especially in women with TSH ≥ 4 mU/L [26]. The gene discussed is TPO; the disease is spindle cell hemangioma.